Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension by Wilding, John P. H., Batterham, Rachel L., Davies, Melanie, Van Gaal, Luc F., Kandler, Kristian, Konakli, Katerina, Lingvay, Ildiko, McGowan, Barbara M., Oral, Tugce Kalayci, Rosenstock, Julio, Wadden, Thomas A., Wharton, Sean, Yokote, Koutaro, Kushner, Robert F.

Get full text

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Tria... by Wadden, Thomas A, Bailey, Timothy S, Billings, Liana K, Davies, Melanie, Frias, Juan P, Koroleva, Anna, Lingvay, Ildiko, O’Neil, Patrick M, Rubino, Domenica M, Skovgaard, Dorthe, Wallenstein, Signe O. R, Garvey, W. Timothy

Get full text

Cardiovascular outcomes, safety, and tolerability with oral semaglutide: insights for managed care by Lingvay, Ildiko, Taddei-Allen, Patty, Dougherty, Tanya

Get full text

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials by Husain, Mansoor, Bain, Stephen C, Holst, Anders Gaarsdal, Mark, Thomas, Rasmussen, Søren, Lingvay, Ildiko

Get full text

Patient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes: a structured qualitative assessment by Edwards, Khary, Uruska, Aleksandra, Duda-Sobczak, Anna, Zozulinska-Ziolkiewicz, Dorota, Lingvay, Ildiko

Get full text

Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy by Vilsbøll, Tina, Bain, Stephen C., Leiter, Lawrence A., Lingvay, Ildiko, Matthews, David, Simó, Rafael, Helmark, Ida Carøe, Wijayasinghe, Nelun, Larsen, Michael

Get full text

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression by Lingvay, Ildiko, Bauer, Robert, Baker-Knight, James, Lawson, Jack, Pratley, Richard

Get full text

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial by Rubino, Domenica, Abrahamsson, Niclas, Davies, Melanie, Hesse, Dan, Greenway, Frank L, Jensen, Camilla, Lingvay, Ildiko, Mosenzon, Ofri, Rosenstock, Julio, Rubio, Miguel A, Rudofsky, Gottfried, Tadayon, Sayeh, Wadden, Thomas A, Dicker, Dror

Get full text

Long-Term Outcomes of Thyroid Nodule AFIRMA GEC Testing and Literature Review: An Institutional Experience by Vora, Amy, Holt, Shelby, Haque, Wasim, Lingvay, Ildiko

Get full text

Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-contr... by Frias, Juan P, Deenadayalan, Srikanth, Erichsen, Lars, Knop, Filip K, Lingvay, Ildiko, Macura, Stanislava, Mathieu, Chantal, Pedersen, Sue D, Davies, Melanie

Get full text

Statins and renal disease progression, ophthalmic manifestations, and neurological manifestations in veterans with diabetes: A retrospective cohort study by Mansi, Ishak A, Chansard, Matheu, Lingvay, Ildiko, Zhang, Song, Halm, Ethan A, Alvarez, Carlos A

Get full text

Pharmacotherapies for Post‐Bariatric Weight Regain: Real‐World Comparative Outcomes by Gazda, Chellse L., Clark, John D., Lingvay, Ildiko, Almandoz, Jaime P.

Get full text

Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical Guide by Lingvay, Ildiko, Leiter, Lawrence A

Get full text

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design by Ryan, Donna H., Lingvay, Ildiko, Colhoun, Helen M., Deanfield, John, Emerson, Scott S., Kahn, Steven E., Kushner, Robert F., Marso, Steve, Plutzky, Jorge, Brown-Frandsen, Kirstine, Gronning, Marianne O.L., Hovingh, G. Kees, Holst, Anders Gaarsdal, Ravn, Henrik, Lincoff, A. Michael

Get full text

Obesity in adults by Lingvay, Ildiko, Cohen, Ricardo V, Roux, Carel W le, Sumithran, Priya

Get full text

Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study by Vora, Amy, de Lemos, James A, Ayers, Colby, Grodin, Justin L, Lingvay, Ildiko

Get full text

When metformin is not enough: Pros and cons of SGLT2 and DPP‐4 inhibitors as a second line therapy by Avogaro, Angelo, Delgado, Elías, Lingvay, Ildiko

Get full text

Correction: Is Metabolic Surgery Having an Identity Crisis? by Cohen, Ricardo V., Lingvay, Ildiko, le Roux, Carel W, Sumithran, Priya

Get full text

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes by Philis‐Tsimikas, Athena, Bajaj, Harpreet S., Begtrup, Kamilla, Cailleteau, Roman, Gowda, Amoolya, Lingvay, Ildiko, Mathieu, Chantal, Russell‐Jones, David, Rosenstock, Julio

Get full text

Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance by Almandoz, Jaime P, Lingvay, Ildiko, Morales, Javier, Campos, Carlos

Get full text